*  Lymphoepithelioma-like carcinoma - Wikipedia
Lymphoepithelioma-like carcinoma (LELC) is a medical term referring to a histological variant of malignant tumor arising from the uncontrolled mitosis of transformed cells originating in epithelial tissue (or in cells that display epithelial characteristics) that bear microscopic resemblance to lymphoepithelioma (nasopharyngeal carcinoma). There is considerable variation in the classification of LELC-while it is perhaps most commonly considered a subtype of squamous cell carcinoma, it can also be classified as a form of large cell carcinoma (i.e. when occurring in the lung), and can be considered as a separate, unique entity. In most anatomical sites, many cases are associated with the Epstein-Barr virus. In the breast, the macroscopic, microscopic, epidemiologic, and prognostic features of LELC are very similar to medullary carcinoma; EBV ...
  https://en.wikipedia.org/wiki/Lymphoepithelioma-like_carcinoma
*  NUS researchers make new discovery of protein as a promising target for treatm... ( Anaplastic thyroid carcinoma (ATC) i...)
Health, ...Anaplastic thyroid carcinoma (ATC) is an aggressive type of cancer wit...Led by Professor H. Phillip Koeffler Senior Principal Investigator a...Thyroid cancer is the most common cancer of the endocrine system. ATC ... The effect of LAMC2 on ATC cells ...,NUS,researchers,make,new,discovery,of,protein,as,a,promising,target,for,treatment,of,ATC,medicine,medical news today,latest medical news,medical newsletters,current medical news,latest medicine news
  http://www.bio-medicine.org/medicine-news-1/NUS-researchers-make-new-discovery-of-protein-as-a-promising-target-for-treatment-of-ATC-125235-1/
*  Nasopharyngeal Carcinoma
... is cancer that occurs in the nasopharynx, which is located behind your nose and above the back of your throat.. Nasopharyngeal carcinoma is difficult to detect early, probably because the nasopharnyx isn't easy to examine and symptoms of nasopharyngeal carcinoma mimic those of many other conditions. Your main treatment options for nasopharyngeal carcinoma are radiation therapy, chemotherapy or a combination of the two. You can work with your doctor to determine the exact approach depending on your particular situation.. Risk factors. Nasopharyngeal carcinoma is common in Southern China. It often affects people aged 30 and older, but occasionally can be seen in the young, including children. It is twice as common in women.. Several risk factors have been found with nasopharyngeal cancer:. Diet: In areas where nasopharyngeal carcinomas are common, people typically eat diets very high in salted fish and preserved meat from ...
  http://www.ammed.com/en/index.php?page=nasopharyngeal-carcinoma
*  Carcinoma ductal invasivo sem outra especificação - Wikipedia
Os carcinomas ductais invasivos sem outra especificação são o maior grupo dos carcinomas invasivos que causam cancros da mama. A designação deve-se à ausência de características diferenciadoras. Os carcinomas que apresentam estas características pertencem a tipos específicos. Neste grupo incluem-se os carcinomas pleomórficos, os carcinomas com células gigantes do tipo osteoclástico, os carcinomas com características de coriocarcinoma e os os carcinomas com características melanóticas. Trata-de de um diagnóstico de exclusão, o que significa que para ser feito um diagnóstico de carcinoma ductal invasivo, todos os tipos particulares devem ser excluídos. Sinn, HP; Kreipe, H (maio de 2013). «A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition.». Breast care (Basel, Switzerland). 8 (2): ...
  https://pt.wikipedia.org/wiki/Carcinoma_ductal_invasivo_sem_outra_especifica%C3%A7%C3%A3o
*  carcinoma - Symptoms, Treatments and Resources for carcinoma
carcinoma - MedHelp's carcinoma Center for Information, Symptoms, Resources, Treatments and Tools for carcinoma. Find carcinoma information, treatments for carcinoma and carcinoma symptoms.
  http://www.medhelp.org/tags/show/1492/carcinoma
*  Carcinoma de células em anel de sinete - Wikipedia
Carcinoma de células em anel de sinete é uma malignidade epitelial caracterizada pelo aparecimento histológico de células em anel de sinete. É uma forma de adenocarcinoma que produz mucina. Quando um adenocarcinoma contém mais de 50% de células em anel de sinete passa a ser denominado carcinoma de células em anel de sinete. Embora seja mais frequente a ocorrência em células glandulares do estômago, pode desenvolver-se noutras partes do corpo como, por exemplo, na próstata, bexiga, vesícula biliar, mama, cólon, estroma ovárico ou testículos. Pode igualmente ser observado em carcinomas das células renais. No entanto, muitos casos de carcinoma de células em anel de sinete são raros, e geralmente não se formam nos pulmões, estômago ou bexiga, embora tenha havido alguns casos nestas áreas. Este tipo de carcinoma aparece principalmente em mulheres e pacientes jovens, enquanto que o ...
  https://pt.wikipedia.org/wiki/Carcinoma_de_c%C3%A9lulas_em_anel_de_sinete
*  "Contributions of the alpha6 integrins to breast carcinoma survival and" by Jun Chung and Arthur M. Mercurio
This review summarizes recent findings that support a key role for the alpha6 integrins (alpha6beta1 and alpha6beta4) in the progression of breast carcinoma. The hypothesis that emerges from the existing data is that both of these integrins have the ability to sustain the survival of breast carcinoma cells, especially in stress conditions such as those that exist in the tumor microenvironment. The mechanisms by which these integrins promote survival appear to involve their ability to regulate the expression of vascular endothelial growth factor (VEGF), either at the level of transcription or translation. VEGF produced by breast carcinoma cells in response to alpha6 integrin regulation can function in an autocrine manner to promote survival signaling.
  http://escholarship.umassmed.edu/cancerbiology_pp/171/
*  Should I be worried if my bladder biopsy shows undifferentiated carcinoma? - Answered by top doctors on HealthTap
Dr. Thompson responded: Possibly. Undifferentiated carcinoma means that the tumor is not showing the normal patterns seen for a transitional or urothelial (lining of the |a href="/topics/bladder" track_data="{
  https://www.healthtap.com/user_questions/37494-should-i-be-worried-if-my-bladder-biopsy-shows-undifferentiated-carcinoma
*  Symptoms in patients with lung carcinoma - Tishelman - 2005 - Cancer - Wiley Online Library
The most striking finding of this study was that the dimension of symptom intensity and the dimension of symptom distress were not equivalent. There also was remarkable consistency in the TSSD-LC data on symptom distress over time in all subgroups examined, whereas patterns of intensity were highly variable. The 3 symptoms-breathing, pain, and fatigue-were associated with the most distress in this sample of 400 patients with inoperable lung carcinoma.. It should be noted, however, that the sample in this study represents the 'healthiest' of this very ill patient group, because participants were younger and had longer survivals than both nonparticipants and the population of patients with inoperable lung carcinoma registered in the same geographic area. Recruitment and participation in this study compared favorably with other studies, considering the well acknowledged difficulties in researching patients with lung carcinoma, debilitated patients, and women ...
  http://onlinelibrary.wiley.com/doi/10.1002/cncr.21398/full
*  Diffuse-type gastric carcinoma (DGC) cell lines with ro | Open-i
Diffuse-type gastric carcinoma (DGC) cell lines with robust overexpression of Met are sensitive to Met inhibitors. (a) DGC and other gastric carcinoma cell line
  https://openi.nlm.nih.gov/detailedresult.php?img=PMC4317844_cas0105-0528-f1&req=4
*  Interval carcinomas of the breast : A group with intermediate outcome. | Base documentaire | BDSP
Background : Interval carcinoma is defined as a carcinoma detected between two mammographic screening rounds after a negative screening. By some authors these carcinomas are considered to be more aggressive than screen-detected carcinomas. Methods : In a group of 937 patients referred for breast cancer in the period 1975-1990,76 interval...
  http://www.bdsp.ehesp.fr/Base/136841/
*  Plus it
1017 Expression and activation of members of the mitogen-activated protein kinase signaling family have been described to function in the progression of breast and prostate carcinoma to a hormone-independent and endocrine therapy resistant phenotype. Using gene expression profiling of human breast carcinoma cells we have identified a member of the mitogen activated protein kinase (MAPK) family, MEK5, whose expression is increased in drug-resistant breast carcinoma cells. To test the role of the MEK5 pathway in tumorigenesis, human breast (MCF-7) carcinoma cells were transfected with a constitutively active MEK5 construct. The MCF7-MEK5 cells exhibited greater proliferation, clonogenic survival and apoptotic resistance in vitro. Using a SCID model of in vivo tumorigenesis we demonstrate that MEK5 expressing breast and ovarian carcinoma cells ...
  http://cancerres.aacrjournals.org/content/65/9_Supplement/237.4
*  Plus it
GADD45G methylation is tumor specific. We further investigated the presence of GADD45G methylation in a large collection of primary tumors, including various lymphomas and carcinomas and normal tissues (Fig. 2A and B; Table 2). GADD45G methylation was detected in multiple tumor types with different frequencies, more frequently in lymphomas than carcinomas and in carcinoma cell lines than primary carcinomas (73% versus 16% in nasopharyngeal carcinoma and 29% versus 11% in esophageal carcinoma; Table 2), indicating that some cell lines may have acquired GADD45G methylation during the establishment or maintenance process. Similar phenomenon has been reported for some TSGs in other tumors (31, 32). None of the 39 normal tissues (12 peripheral blood mononuclear cells, 3 lymph nodes, 10 nasopharynx, 7 normal ...
  http://clincancerres.aacrjournals.org/content/11/18/6442
*  Prognostic relevance of LGALS3BP in human colorectal carcinoma - pdf descargar
Prognostic relevance of LGALS3BP in human colorectal carcinoma. . Biblioteca virtual para leer y descargar libros, documentos, trabajos y tesis universitarias en PDF. Material universiario, documentación y tareas realizadas por universitarios en nuestra biblioteca. Para descargar gratis y para leer online.
  http://libros.duhnnae.com/2017/jun9/149884902795-Prognostic-relevance-of-LGALS3BP-in-human-colorectal-carcinoma.php
*  A036 | Ovarian Carcinoma Cells (OCC) | SinoProt
Ovarian cancer is a cancer that forms in an ovary. It results in abnormal cells that have the ability to invade or spread to other parts of the body. SK-OV-3, NIH:OVCAR-3 and HO-8910 are the ovarian carcinoma cell lines derived from human ovarian tumor. Studies were carried out to determin
  http://sinoprot.com/items/A036
*  What is Epithelial Carcinoma? (with pictures)
Epithelial carcinoma is an abnormal growth of cells in the epithelium, which is the tissue that lines the organs. The signs of...
  http://www.wisegeek.com/what-is-epithelial-carcinoma.htm
*  I Have Carcinoma, Small Cell
Do You Have Carcinoma, Small Cell? Join friendly people sharing true stories in the I Have Carcinoma, Small Cell group. Find support forums, advice and chat with groups who share this life experience. Carcinoma, Small Cell anonymous support group wit...
  http://www.experienceproject.com/groups/Have-Carcinoma-Small-Cell/97319
*  Estudi del proteasoma i altres dianes terapèutiques en el melanoma i el carcinoma d'endometri
Dada la resistencia a la quimioterapia que presenta el melanoma y el carcinoma de endometrio avanzado, es importante aquella investigación destinada a buscar dianas terapéuticas. En este trabajo hemos investigado los efectos de análogos de la somatostatina (SAs), de inhibidores del proteasoma (PI) como Bortezomib, del inhibidor de receptores tirosina cinasa Sunitinib y la combinación de Sunitinib y Bortezomib en líneas celulares de melanoma. Esta combinación también la hemos testado en el carcinoma de endometrio. Se observa que las células de melanoma expresan varios receptores de la somatostatina. Los PI son eficientes a la hora de inducir una parada en el ciclo celular y apoptosis. Las líneas celulares que presentan PDGFR α i VEGFR2 son sensibles a Sunitinib, y éste interacciona con Bortezomib de forma sinérgica. En el carcinoma de endometrio, Sunitinib induce una parada en el ciclo celular, apoptosis, inhibe la via NFκB e interacciona sinérgicamente con ...
  http://www.tdx.cat/handle/10803/83625
*  What are Carcinomas?
Carcinomas are cancers or malignancies that begin in the epithelial tissues. Epithelial cells are the cells that line the entire surface of the body as well as the internal structures and cavities. Carcinomas may affect the breast, lung, prostate, and colon and are among the most common types of cancer in adults.
  https://www.news-medical.net/health/What-are-Carcinomas.aspx
*  Plus it
Although the β4 integrin has been implicated in the genesis and progression of carcinomas based on data from cell lines and mouse models (reviewed in refs. 3, 13, 14), data on its relationship to the clinical properties of human carcinomas are relatively scant, although interesting data exist on the correlation between β4 mRNA expression and breast tumor size and grade (18). In general, however, existing assumptions on β4 expression in carcinomas are rather generic in this regard: β4 expression can be maintained (e.g., breast and squamous), increased (e.g., thyroid), or suppressed (e.g., prostate) during the progression from normal epithelium to carcinoma (reviewed in ref. 32). For the most part, such studies have not considered the complex pathology of specific carcinomas or a potential association of β4 with clinical outcome. Using a two-pronged approach that involved analysis of gene profiling data from ...
  http://clincancerres.aacrjournals.org/content/14/4/1050
*  Engineered immune cells could improve outcomes in nasopharyngeal carcinoma - ONA
Researchers believe that a new method of genetically engineering immune cells could lead to improved treatment of patients with nasopharyngeal carcinoma.
  http://www.oncologynurseadvisor.com/web-exclusives/engineered-immune-cells-could-improve-outcomes-in-nasopharyngeal-carcinoma/article/408256/
*  Epidemiology And Risk Factors In Carcinomas Of The Large Bowel
Corina Lavinia Gruia(1), CT Streba(2), Corina Maria Dochita(1), CC Vere(2), AG Ionescu(2) (1)Department of Pathology, County Emergency University Hospital University of Medicine and Pharmacy Craiova (2)Department of Internal Medicine, County Emergency University Hospital, University of Medicine and Pharmacy, Craiova; Abstract Colorectal carcinoma (CRC) represents one of the most common types of carcinoma in both males and females, being encountered mainly in developed countries. North
  http://www.chsjournal.org/archive/vol36-no4-2010/updates/epidemiology-and-risk-factors-in-carcinomas-of-the-large-bowel
*  miR-526a regulates apoptotic cell growth in human carcinoma cells. | Sigma-Aldrich
Sigma-Aldrich offers abstracts and full-text articles by [Xiaoli Yang, Cui Wang, Changzhi Xu, Zhifeng Yan, Congwen Wei, Kai Guan, Shengli Ma, Ye Cao, Liping Liu, Deyong Zou, Xiang He, Buchang Zhang, Qingjun Ma, Zirui Zheng].
  https://www.sigmaaldrich.com/catalog/papers/26002288
*  Carcinoma - Conservapedia
Carcinoma is any of the various types of cancerous tumors that form in the epithelial tissue, the tissue forming the outer layer of the body surface and lining the digestive tract and other hollow structures. Examples of this kind of cancer include, breast, lung, and prostate cancer. ...
  http://www.conservapedia.com/Carcinoma
*  DSpace@MIT: Browsing Department of Biology by Title
Carcinomas are solid tumors arising from epithelial tissue, and account for the majority of cancer deaths in the United States. In most occurrences of carcinoma, it is the metastases that kill, not the primary tumor. The ...
  http://dspace.mit.edu/handle/1721.1/7761/browse?rpp=20&order=ASC&sort_by=1&etal=-1&type=title&starts_with=X